An mRNA vaccine that targets several aspects of C. difficile’s ability to cause severe disease prevented major symptoms and death in mice.

H. pylori infections occur across the world due to exposure to saliva or stool in contaminated water or food. Learn how the ...

Study finds underutilization of fidaxomicin, a recommended treatment for C. diff infection, despite increased use in hospitals.

The US Department of Health and Human Services (HHS) last week announced funding for a project that will use artificial ...

He said the number-one injury among military personnel is traumatic brain injury, so advancing new treatments is a priority. The military also places a high priority on being able to treat more ...

Updated guidelines recommend fidaxomicin as the first-line agent for C difficile infection, but researchers found use in US ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...

Standard ALL treatment usually takes between 2 to 3 years. The maintenance phase takes up most of this time as it lasts 2 years. During the maintenance phase people often go back to work or college.

Simon Parkinson had no coordination or movement in his right arm and leg when he was restrained and transported to hospital ...

Learn more about the newest treatments and promising avenues of research. If you have HAE, you most likely don’t have enough C1-inhibitor protein or, if you have it, the protein does not work as ...

From combining treatments in unprecedented ways to deploying artificial intelligence for personalised medicine, a raft of new advances in the fight against cancer have been presented at the European ...